ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
| Autor: | Zander, A R1, Kröger, N1, Schleuning, M2, Finke, J3, Zabelina, T1, Beelen, D4, Schwerdtfeger, R5, Baurmann, H5, Bornhäuser, M6, Ehninger, G6, Fauser, A A7, Kiehl, M7, Trenschel, R4, Ottinger, H D4, Bertz, H3, Berger, J8, Kolb, H-J2, Schaefer, U W4 |
|---|---|
| Zdroj: | Bone Marrow Transplantation. Aug2003, Vol. 32 Issue 4, p355-361. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|